Galectin Therapeutics Statistics
NASDAQ: GALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.69-0.12 (-4.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Galectin Therapeutics by the numbers
Galectin Therapeutics has a market capitalization of $271.4 million based on 100.88M shares outstanding. With trailing EPS of $-0.32, Galectin Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.7% below its 50-day average and 16.3% below its 200-day average.
Average daily trading volume is 252.31K shares, or about $678,703 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GALT valuation vs. peer median
| Metric | GALT | Peer median | Difference |
|---|---|---|---|
| Market cap | $271.35M | $272.21M | -0% |
| Avg. volume | 252.31K | 771.61K | -67% |
Peer median across 8 companies: VCRE, RLMD, FULC, GLSI, EBS, ALT, PRLD, BNTC.
Valuation
- Market cap
- $271.35M
- EPS (TTM)
- $-0.32
- Shares outstanding
- 100.88M
Price and trading
- Previous close
- 2.81
- Open
- 2.80
- Day range
- 2.67 – 2.93
- 52-week range
- 2.03 – 7.13
- 52-week change
- -49.72%
- Beta
- —
- Volume
- 257.65K
- Average volume
- 252.31K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 271.35M
- Forward Pe
- -1.60
- Eps
- -0.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.13
- Week52 Low
- 2.03
- Avg Volume
- 252.31K
- Shares Outstanding
- 100.88M
- Ma50
- 3.53
- Ma200
- 3.21
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -62.27%
- Pct From52w Low
- 32.51%